CENTOGENE

CENTOGENE is a Rostock-based leader in rare disease diagnostics and data-driven precision medicine, operating at the intersection of diagnostics, genomics, and pharmaceutical services. The company's core assets are its proprietary CENTOGENE Biodatabank, containing multiomic data from over 1 million individuals, and its integrated diagnostic platform, CentoDx, which supports a suite of services from reproductive genetics to whole genome sequencing. By combining diagnostic testing for patients with data partnership services for pharma, CENTOGENE creates a closed-loop ecosystem that accelerates diagnosis for individuals and de-risks drug development for industry partners. Its strategy is built on global commercial reach, a focus on multiomics, and deep expertise in rare and neurodegenerative diseases.

Integrated multiomic diagnostic platform (MOx) powered by the CentoDx bioinformatics knowledge management system and fueled by the CENTOGENE Biodatabank containing phenotypic and multiomic data from over 1 million individuals.

CENTOGENE competes in the crowded genetic diagnostics market against large commercial labs (e.g., Quest Diagnostics, Labcorp), specialized rare disease-focused companies (e.g., Invitae, PreventionGenetics), and academic medical centers. Its primary differentiation is its integrated model combining diagnostic testing with a proprietary, rare-disease-enriched biodatabank for pharmaceutical R&D, a niche where it competes with data-centric companies like Foundation Medicine (now Roche) and DNAnexus.